B-lineage prolymphocytic leukemia as a distinct clinicopathologic entity

Area of Science:

• Hematology
• Immunology
• Pathology

Background:

• Prolymphocytic leukemia (PLL) was initially described as a variant of chronic lymphocytic leukemia (CLL).
• Heterogeneity in PLL's clinical and immunologic features raises questions about its classification as a single entity.
• Detailed pathologic descriptions have been lacking for PLL cases.

Observation:

• Three patients meeting diagnostic criteria for PLL were analyzed using pathologic and immunologic methods.
• Distinctive pseudonodular features were observed in the spleens of these patients.
• Malignant prolymphocytes were identified as B-lineage cells.

Findings:

• B-lineage prolymphocytes expressed surface IgM and IgD, and HLA-DR antigen.
• These cells lacked E-rosette formation and natural killer cell activity.
• The study affirms B-lineage prolymphocytic leukemia as a distinct entity.

Implications:

• PLL is characterized by unique pathologic, clinical, and immunobiologic features.
• This finding clarifies the classification and understanding of prolymphocytic leukemia.
• Further research into B-lineage PLL can lead to improved diagnostic and therapeutic strategies.